Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer
Politi K, Gettinger S. Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer. Clinical Cancer Research 2014, 20: 5576-5578. PMID: 25228532, PMCID: PMC4401422, DOI: 10.1158/1078-0432.ccr-14-2306.Commentaries, Editorials and LettersConceptsALK inhibitorsLung cancerSmall molecule ALK inhibitorsMutational profileALKDifferent mutantsCancerInhibitorsCommon mechanismDifferential sensitivityPatientsTherapyTumors